• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN TRAILBLAZER SUPPORT CATHETER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN TRAILBLAZER SUPPORT CATHETER; CATHETER, PERCUTANEOUS Back to Search Results
Model Number SC-035-135
Medical Device Problem Codes Fracture (1260); Difficult to Remove (1528); Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 08/25/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Physician intended to use a trailblazer support catheter during treatment of a calcified cto (chronic total occlusion-100%) in the patient¿s proximal left common iliac artery and superficial femoral artery.Severe vessel calcification and tortuosity are reported.Ifu was followed.It is reported the catheter broke while removing the device over the common iliac bifurcation.The catheter fragments remained stuck on the guidewire.A 10mm gooseneck snare was used to retrieve the broken catheter.When the trailblazer was removed from the patient, a long sheath was used to crossover bifurcation and treat the intended vessel.No further injury reported.
 
Additional Manufacturer Narrative
Additional information: all components of the device were removed from the patient.There was no vessel damage noted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Additional Manufacturer Narrative
Product analysis: the trailblazer was returned to medtronic investigation lab for evaluation.The device inside a red biohazard bag with portion of the trailblazer pouch.No ancillary devices were included.The trailblazer was fractured apart into two segments.Dried blood was observed within the catheter lumen.The distal segment showed all three marker bands were present and accounted for.The distal segment was approximately 14cm long.The proximal end of the segment showed a radial ductile fracture.The proximal end of the shaft at the area of the fracture showed buckling of the catheter outer.The proximal segment showed the strain relief was consistent with the product labeling.(indicated 0.035" x 135cm).The total working length of the proximal segment was approximately 122cm.The distal end of this segment showed a radial ductile fracture face.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRAILBLAZER SUPPORT CATHETER
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
MDR Report Key10464415
Report Number2183870-2020-00272
Device Sequence Number16938238
Product Code DQY
UDI-Device Identifier00763000104818
UDI-Public00763000104818
Combination Product (Y/N)N
Initial Reporter StateSD
Initial Reporter CountryUS
PMA/510(K) Number
K092299
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/05/2023
Device Model NumberSC-035-135
Device Catalogue NumberSC-035-135
Device Lot NumberB019738
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/31/2020
Initial Date Received by Manufacturer 08/25/2020
Supplement Date Received by Manufacturer08/29/2020
10/12/2020
Initial Report FDA Received Date08/28/2020
Supplement Report FDA Received Date09/02/2020
10/19/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age77 YR
Patient Weight68
-
-